Nasopharyngeal Carcinoma: all 824 studies
Page 1 of 9. Open to participants first (281), then studies with results posted, then the rest; newest registration first within each.
- Local Ablation Plus Systemic Therapy for Metachronous Liver and/or Lung Oligometastases From Nasopharyngeal CarcinomaNot yet recruitingNCT07824856Phase 2
- Dynamic Risk Prediction of Severe Myelosuppression in Nasopharyngeal CarcinomaRecruitingNCT07819656
- A Study of BL-M08D1 in Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma and Other Solid TumorsNot yet recruitingNCT07818486Phase 1/2
- A Study of BL-B01D1 With or Without PD-1 Monoclonal Antibody in Patients With High-Risk Locally Advanced Nasopharyngeal CarcinomaNot yet recruitingNCT07797881Phase 2
- Prophylactic Nanocrystalline Megestrol Acetate Versus Placebo for Chemoradiotherapy-Related Anorexia in Nasopharyngeal CarcinomaRecruitingNCT07796789Phase 3
- Induction Chemotherapy Response-Guided Reduced-Dose Radiotherapy for Nasopharyngeal CarcinomaNot yet recruitingNCT07789158Phase 2
- A Study of Anti-PD-1 Antibody With or Without BL-B01D1 as Maintenance Therapy Following Anti-PD-1 Antibody Plus Chemotherapy for the First-line Treatment of Recurrent or Metastatic Nasopharyngeal Carcinoma (PANKU-NPC02)Not yet recruitingNCT07783321Phase 3
- Becotatug Vedotin Combined With a PD-1 Inhibitor in the Treatment of Locally Advanced Recurrent Nasopharyngeal Carcinoma.RecruitingNCT07781358Phase 2
- Impacted Tooth Management and Osteoradionecrosis Risk in NPCNot yet recruitingNCT07764887Not applicable
- Dynamic Risk-adapted EBV-DNA and MRI-guided De-concurrent Chemotherapy in Nasopharyngeal CarcinomaRecruitingNCT07762976Phase 2
- Radscopal Radiotherapy Plus Immunotherapy for Chemotherapy-Ineligible Patients With Newly Diagnosed Metastatic Nasopharyngeal Cancer: A Single-Center, Open-Label, Phase II StudyNot yet recruitingNCT07756190Phase 2
- A Study to Evaluate ARV-6723 Alone and With Pembrolizumab in Participants With Advanced Solid TumorsRecruitingNCT07749586Phase 1/2
- Efficacy and Safety of TPC Induction Chemotherapy Combined With Nimotuzumab and Toripalimab "Immune Sandwich" Regimen Versus Full-Course Immunotherapy for Locally Advanced Nasopharyngeal CarcinomaRecruitingNCT07706985Phase 3
- Evaluating the Optimal Timing of Acupuncture for Managing Chemoradiation-induced Xerostomia in Patients With Head and Neck CancersNot yet recruitingNCT07674706Not applicable
- Docetaxel and SX-682 in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma, Salivary Gland Carcinoma, and Advanced Prostate CancerRecruitingNCT07667400Phase 1/2
- A Study of Cemiplimab and Fianlimab in People With Nasopharyngeal CarcinomaNot yet recruitingNCT07650266Phase 1
- Real-World RAIRI-Guided Risk Stratification for Adjuvant Therapy Benefit After Chemoradiotherapy in NPCRecruitingNCT07618078
- RAIRI Model-Guided Adjuvant Therapy in Nasopharyngeal CarcinomaRecruitingNCT07590024Phase 3
- Phase I Study of Becotatug Vedotin for Safety and Efficacy in EGFR-Positive Pediatric Relapsed/Refractory or Metastatic Solid TumorsRecruitingNCT07584499Phase 1
- Sintilimab Combined With Anlotinib and Taxane-Based Chemotherap for Recurrent/Metastatic Nasopharyngeal CarcinomaRecruitingNCT07581821Phase 2
- A Multicenter, Prospective, Phase III Clinical Study of Proton Intensity-modulated Radiotherapy Versus Photon Intensity-modulated Radiotherapy for Untreated Non-metastatic Nasopharyngeal CarcinomaNot yet recruitingNCT07578727Not applicable
- Taurine for the Prevention and Treatment of Radiation-induced Oral Mucositis in Patients With Nasopharyngeal CarcinomaNot yet recruitingNCT07567742Phase 2
- Evaluating Ivonescimab in PD-1 Resistant Recurrent or Metastatic Nasopharyngeal CarcinomaNot yet recruitingNCT07565389Phase 2
- Becotatug Vedotin Plus PD-1 Monoclonal Antibody and Radiotherapy for Unresectable Locally Recurrent Nasopharyngeal CarcinomaNot yet recruitingNCT07555860Phase 2
- Pseudomembrane Removal for Post-RT Nasopharyngeal NecrosisNot yet recruitingNCT07552883Not applicable
- GAPP Induction and Concurrent Chemoradiotherapy for High-risk Locoregionally Advanced NPC.Not yet recruitingNCT07540390Phase 3
- Becotatug Vedotin Plus Sintilimab in Locoregionally Advanced NPCRecruitingNCT07459296Phase 3
- Proton Therapy for Recurrent Nasopharyngeal CarcinomaRecruitingNCT07412314Not applicable
- CROSSROAD: Treatment Regimen Switch - Re-induction Chemotherapy vs. Direct Radiotherapy in LANPC With Inadequate Response to Induction ChemotherapyNot yet recruitingNCT07399158
- Scipibaimab Combined With Tislelizumab in Patients With First-Line Treatment-Failed Recurrent/Metastatic Nasopharyngeal CarcinomaNot yet recruitingNCT07388758Phase 2
- Toripalimab Combined With Different Platinum-Based Induction Chemotherapy Regimens for Locally Advanced Nasopharyngeal CarcinomaRecruitingNCT07362979Phase 2
- Proton vs Photon IMRT in Locally Advanced Nasopharyngeal Carcinoma: A Phase III TrialRecruitingNCT07340515Phase 3
- MRG003 Induction and Capecitabine Maintenance With PD-1 in Locally Recurrent NPCRecruitingNCT07331428Phase 2
- 40.2Gy Versus 49.2Gy Radiotherapy in Low-Risk Target Volume for Chemosensitive Stage II Nasopharyngeal CarcinomaRecruitingNCT07328854Phase 3
- Reduced-dose Versus Conventional-dose Intensity-modulated Radiation Therapy for Locally Advanced Nasopharyngeal Carcinoma With Remission After Induction Chemotherapy and ImmunotherapyRecruitingNCT07328841Phase 3
- Sapylin Versus Dexamethasone Inhalation for CCRT-Induced Oral Mucositis in Nasopharyngeal CarcinomaRecruitingNCT07327216Phase 3
- LDRT Combined With Toripalimab and Chemotherapy for Recurrent/Metastatic NPCRecruitingNCT07325539Phase 2
- Chidamide in Combination With Toripalimab and Anlotinib in Recurrent/Metastatic Nasopharyngeal Carcinoma.Not yet recruitingNCT07320963Phase 1/2
- Becotatug Vedotin as Adjuvant Therapy For High-risk Nasopharyngeal CarcinomaNot yet recruitingNCT07303283Phase 2
- Individualized Neck Cervical Irradiation Prophylaxis Trial of NPCRecruitingNCT07303023Phase 3
- Induction High-Low Dose Radiotherapy Plus Anti-PD-1 Followed by Definitive Radiotherapy in Recurrent Nasopharyngeal Carcinoma (Single-Arm Phase II)RecruitingNCT07277764Phase 2
- A Study of YL201 in Combination With Toripalimab and With or Without Cisplatin in Nasopharyngeal Carcinoma.RecruitingNCT07258979Phase 1/2
- A Clinical Study of Hetrombopag for Prevention of Thrombocytopenia Induced by Gemcitabine Plus Cisplatin in the Treatment of Nasopharyngeal CarcinomaNot yet recruitingNCT07252375Phase 2
- Integrating Allogeneic NK Cells in High-risk Advanced Stage III-IV Nasopharyngeal Cancer PatientsNot yet recruitingNCT07247201Phase 1/2
- Molecular Research on Predictive Efficacy and New Therapeutic Targets for Nasopharyngeal CarcinomaNot yet recruitingNCT07198802
- Phase III Non-Inferiority Trial: Reduced-Target vs. Full-Target IMRT After Chemo in Immunotherapy-Treated Metastatic Nasopharyngeal CancerRecruitingNCT07188584Phase 3
- EBV Lytic Reactivation Therapy Combined With PD-1 Antibody in Recurrent/Metastatic Nasopharyngeal CarcinomaNot yet recruitingNCT07138989Phase 2
- Precise Guidance of Adaptive Radiotherapy for Nasopharyngeal CarcinomaRecruitingNCT07137052
- Toripalimab, Induction Chemotherapy, Radiation Therapy With Omega-3 for Locally Advanced Nasopharyngeal CarcinomaNot yet recruitingNCT07136519Phase 2
- Perioperative Chemotherapy and Immunotherapy for Locally Recurrent Nasopharyngeal CarcinomaNot yet recruitingNCT07129772Phase 2
- Radiotherapy Omitting Prophylactic Neck Irradiation With Neoadjuvant and Adjuvant Toripalimab in Nasopharyngeal CarcinomaNot yet recruitingNCT07110558Phase 2
- Iparomlimab and Tuvonralimab Combined With Nimotuzumab in Recurrent or Metastatic NPC After First-line Treatment Failure: A Single-arm Phase IIa Clinical TrialRecruitingNCT07101744Phase 2
- Watch-and-Wait After Immunochemotherapy in Locally Recurrent Nasopharyngeal CarcinomaNot yet recruitingNCT07088484
- Effect of Nutritional Management on Patients With Concurrent Chemoradiotherapy for Nasopharyngeal CarcinomaRecruitingNCT07085988Phase 2
- An International Study on Pediatric Patients With Rare Tumors.RecruitingNCT07072143
- Shrinking the Anterior Border of CTV2 for Nasopharyngeal Carcinoma to Reduce the Radiation of Nasal CavityNot yet recruitingNCT07072000Phase 3
- Combination Therapy for PD-1 Resistant Recurrent or Metastatic Nasopharyngeal Carcinoma: A Bayesian Adaptive Phase II TrialRecruitingNCT07070479Phase 2
- Tislelizumab Combined With Capecitabine for Nasopharyngeal Carcinoma With Residual EBV DNA After RadiotherapyRecruitingNCT07067268Phase 2
- Ivonescimab Combined With Chemoradiotherapy in High-Risk Locoregionally Advanced Nasopharyngeal CarcinomaNot yet recruitingNCT07064902Phase 2
- Screening for Early Diagnosis of Nose CancerRecruitingNCT07019870Not applicable
- Phase III Non-Inferiority Trial of Proton Versus Photon Therapy for Nasopharyngeal CarcinomaRecruitingNCT07000643Phase 3
- TC as Adjuvant Therapy After Surgery for Locally Recurrent Resectable Nasopharyngeal Carcinoma: a Single-arm Clinical TrialNot yet recruitingNCT06987123Phase 2
- SSTR2 Imaging With [68Ga]Ga-DOTA-TOC PET/CT in NPCRecruitingNCT06982300Phase 1/2
- Testing Whether Cemiplimab (REGN2810) Plus CDX-1140 Given Prior to Surgery Are Better Than Cemiplimab (REGN2810) Alone in Patients With Stage III-IV Head and Neck CancerRecruitingNCT06980038Phase 2
- A Study of MRG003 in Combination With Pucotenlimab Versus Chemotherapy in the Treatment of Patients With Recurrent or Metastatic Nasopharyngeal CarcinomaRecruitingNCT06976190Phase 3
- Application of 18F-FDG PET/MRI for Initial Staging in Locally Advanced Nasopharyngeal CarcinomaNot yet recruitingNCT06947759
- TN Induction and Adjuvant Therapy for Resectable Local Recurrent Nasopharyngeal CarcinomaRecruitingNCT06912711Phase 2
- Reduced Dose Radiotherapy vs Standard Dose Radiotherapy for Early Stage Nasopharyngeal CarcinomaRecruitingNCT06912698Phase 3
- PD-1 Antibody Sintilimab Combined With Capecitabine as Adjuvant Therapy for High-Risk Nasopharyngeal CarcinomaNot yet recruitingNCT06900218Phase 3
- JMT101 Combined With Mitoxantrone Liposome for Nasopharyngeal CancerNot yet recruitingNCT06892431Phase 2
- Metastatic Nasopharyngeal CarcinomaRecruitingNCT06886347Phase 1
- Comparison and Strategy Optimization of Plasma EBV DNA and P85-Ab with VCA/EBNA1-IgA for Screening Nasopharyngeal Carcinoma in High-risk AreasRecruitingNCT06870435Not applicable
- TMV Vaccine Therapy Alone and With Pembrolizumab for the Treatment of Recurrent and/or Metastatic Head and Neck Squamous Cell CancerRecruitingNCT06868433Phase 1
- CD70-targeted immunoPET Imaging of Malignant CancersRecruitingNCT06852638Phase 2
- GAPP Induction and Concurrent Chemoradiotherapy Followed by Toripalimab Maintenance for Nasopharyngeal Carcinoma.RecruitingNCT06851247Phase 2
- A Phase II Study to Evaluate HLX43 in Subjects With Recurrent/Metastatic Nasopharyngeal Carcinoma Failed or Intolerance to Second-line TherapyRecruitingNCT06839066Phase 2
- Development and Validation of a Deep Learning Model to Predict Distant Metastases in Nasopharyngeal Carcinoma Using Whole Slide Imaging and MRIRecruitingNCT06831357
- A Deep Learning Model for Diagnosing Lymph Node Metastasis in Nasopharyngeal Carcinoma(NPC)RecruitingNCT06829147
- EGFR Antibody Combined With PD-1 Inhibitor and Chemotherapy in R/M Nasopharyngeal CarcinomaRecruitingNCT06802835Phase 1/2
- Hypofractionated Radiotherapy for Nasopharyngeal CarcinomaRecruitingNCT06796270Not applicable
- LDRT and Chemoimmunotherapy in NPC With Liver MetastasisRecruitingNCT06788002Phase 2
- "Xijiang Project" Screening Cohort for NPCRecruitingNCT06787456
- A Phase II Study of TPF With PD-1 Inhibitor Induction Therapy for Locally Advanced Nasopharyngeal CarcinomaNot yet recruitingNCT06781112Phase 2
- Reducing Dose and Irradiated Volume in Cervical Prophylactic Irradiation for Nasopharyngeal CancerNot yet recruitingNCT06775756Phase 3
- Prognostic Value of TIL in Nasopharyngeal CarcinomaEnrolling by invitationNCT06763640
- KSD-101 Therapy for Standard Treatment Failed EBV-associated Nasopharyngeal Carcinoma: an Exploratory Clinical TrialNot yet recruitingNCT06752473Early Phase 1
- Sintilimab Combined With Bevacizumab and TP Chemotherapy in the Treatment of High Risk Locally-advanced NPCNot yet recruitingNCT06752382Phase 2
- Prophylactic Radiotherapy Optimization for Enhanced Thyroid Function Protection in NPCRecruitingNCT06752239Phase 3
- Monitoring Salivary Gland Injury in Nasopharyngeal Carcinoma Patients After Radiotherapy Using Multi-Modal RadiomicsNot yet recruitingNCT06751381
- QL1706 (PD-1/CTLA-4 Bi-specific Antibody) and Chemoradiotherapy in Locoregionally-advanced Nasopharyngeal Carcinoma.RecruitingNCT06749899Phase 3
- ChemoRT With and Without Dental Stent for Taste Protection in NPC PatientsRecruitingNCT06733948Phase 2
- Treatment with Intensity Modulated Radiotherapy on the Change of Cognitive Function in Nasopharyngeal Carcinoma Patients: a Prospective Cohort StudyNot yet recruitingNCT06695936
- Surgery Alone Verus Sugery Combined with Dose-reduced Radiotherapy for Newly Diagnosed Stage I Nasopharyngeal CarcinomaRecruitingNCT06688760Not applicable
- Induction Chemotherapy Response-Guided Radiation for EBV-Associated Nasopharyngeal CarcinomaRecruitingNCT06682442Not applicable
- Neoadjuvant and Adjuvant Sintilimab Combined with Chemoradiotherapy Versus Chemoradiotherapy Alone in Stage TanyN3M0 Nasopharyngeal CarcinomaNot yet recruitingNCT06680115Phase 2
- Under Whole-course of Immunotherapy, Gradient Fractionated RT with CCT Versus CFRT with CCT for LANPC Who Achieved PR Post Induction Chemotherapy.RecruitingNCT06675214Phase 3
- Nab-TPC vs GP Combined With Camrelizumab in the Treatment of Recurrent/Metastatic Nasopharyngeal CarcinomaRecruitingNCT06669611Phase 3
- Arabic PRO Measures for Head and Neck Cancer Radiotherapy.RecruitingNCT06662929
- Remote Audiometry to Monitor for Treatment-Related Hearing Loss in Patients With H&N SCC Receiving Cisplatin and/or RadiationRecruitingNCT06662058Not applicable
- Irinotecan Liposome Combined with S-1 in PD-1/L1 Inhibitor Refractory Recurrent or Metastatic NPCRecruitingNCT06657690Phase 2